Lean Mass Changes With Semaglutide in Adults With Type 1 Diabetes and Overweight/Obesity. (opens ClinicalTrials.gov)
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Enrolment
- 40
- Started
- 2026-10-13
- Last update
- 2026-10-23
Conditions: Type 1 Diabetes, Overweight , Obesity
Interventions: Semaglutide, Placebo